Home › Funds › Flagship Pioneering, LLC › FHTX
Flagship Pioneering, LLC position in FHTX
FOGHORN THERAPEUTICS INC · Health Care
Flagship Pioneering, LLC reported holding 12,674,120 shares of FHTX (FOGHORN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$61.8M, representing 4.02% of its reported portfolio and ranking #4 among its reported holdings. Flagship Pioneering, LLC has disclosed FHTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Flagship Pioneering, LLC's FHTX position evolved
Flagship Pioneering, LLC first disclosed a stake in FHTX in Q3 2023 at 12,674,120 shares (US$63.4M). The position peaked in Q3 2024 at 12,674,120 shares, worth US$118.0M. Across 12 filings, Flagship Pioneering, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 12,674,120 shares valued at US$61.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 12.67M | $63.37M | New |
| Q4 2023 | 12.67M | $81.75M | Hold |
| Q1 2024 | 12.67M | $85.04M | Hold |
| Q2 2024 | 12.67M | $72.88M | Hold |
| Q3 2024 | 12.67M | $118.00M | Hold |
| Q4 2024 | 12.67M | $59.82M | Hold |
| Q1 2025 | 12.67M | $46.26M | Hold |
| Q2 2025 | 12.67M | $59.57M | Hold |
| Q3 2025 | 12.67M | $61.98M | Hold |
| Q4 2025 | 12.67M | $68.44M | Hold |
| Q1 2026 | 12.67M | $60.58M | Hold |
| Q2 2026 | 12.67M | $61.85M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FHTX and 13F data
FHTX (FOGHORN THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in FHTX — the largest reported positions include BVF INC/IL (US$28.5M), Euclidean Capital LLC (US$7.7M), Birchview Capital, LP (US$1.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FHTX
- BVF INC/IL 5.84M sh · $28.51M · Q2 2026
- Euclidean Capital LLC 1.57M sh · $7.68M · Q2 2026
- Birchview Capital, LP 281.94K sh · $1.38M · Q2 2026
- B Group, Inc. 200.00K sh · $976.00K · Q2 2026
More on Flagship Pioneering, LLC
FAQ
How long has Flagship Pioneering, LLC held FHTX?
Flagship Pioneering, LLC has disclosed FHTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Flagship Pioneering, LLC's current position in FHTX?
As of Q2 2026, Flagship Pioneering, LLC holds 12.67M shares of FHTX (FOGHORN THERAPEUTICS INC), valued at $61.85M, representing 4.02% of its reported portfolio and ranking #4.
Has Flagship Pioneering, LLC been buying or selling FHTX?
In the latest 13F filing (Q2 2026), Flagship Pioneering, LLC held unchanged its position in FHTX. The position peaked in Q3 2024 at 12.67M shares.
Which other funds hold FHTX?
Other major institutional holders of FHTX include BVF INC/IL, Euclidean Capital LLC, Birchview Capital, LP, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.